Scott Woods, MD

2025

• Functional Correlates of Atypical Visuoperceptual Organization in a Multisite Clinical High-Risk Sample

  Pokorny V, Tran T, Williams T, Kenney J, Silverstein S, Gold J, Waltz J, Schiffman J, Ellman L, Strauss G, Walker E, Woods S, Powers A, Corlett P, Mittal V. Functional Correlates of Atypical Visuoperceptual Organization in a Multisite Clinical High-Risk Sample. Journal Of Psychopathology And Clinical Science 2025, 134: 527-539. PMID: 40193439, PMCID: PMC12162206, DOI: 10.1037/abn0000992.

  Peer-Reviewed Original Research

  Altmetric

  MeSH Keywords and Concepts

• The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

  Mathalon D, Nicholas S, Roach B, Billah T, Lavoie S, Whitford T, Hamilton H, Addamo L, Anohkin A, Bekinschtein T, Belger A, Buccilli K, Cahill J, Carrión R, Damiani S, Dzafic I, Ebdrup B, Izyurov I, Jarcho J, Jenni R, Jo A, Kerins S, Lee C, Martin E, Mayol-Troncoso R, Niznikiewicz M, Parvaz M, Pogarell O, Prieto-Montalvo J, Rabin R, Roalf D, Rogers J, Salisbury D, Shaik R, Shankman S, Stevens M, Suen Y, Swann N, Tang X, Thompson J, Tso I, Wenzel J, Zhou J, Addington J, Alameda L, Arango C, Breitborde N, Broome M, Cadenhead K, Calkins M, Castillo-Passi R, Chen E, Choi J, Conus P, Corcoran C, Cornblatt B, Diaz-Caneja C, Ellman L, Fusar-Poli P, Gaspar P, Gerber C, Glenthøj L, Horton L, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim M, Kim S, Koutsouleris N, Kwon J, Langbein K, Mamah D, Mittal V, Nordentoft M, Pearlson G, Perez J, Perkins D, Powers A, Sabb F, Schiffman J, Shah J, Silverstein S, Smesny S, Stone W, Strauss G, Upthegrove R, Verma S, Wang J, Wolf D, Zhang T, Bouix S, Pasternak O, Cho K, Coleman M, Dwyer D, Nunez A, Tamayo Z, Wood S, Kahn R, Kane J, McGorry P, Bearden C, Nelson B, Woods S, Shenton M, Light G. The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures. Schizophrenia 2025, 11: 85. PMID: 40480970, PMCID: PMC12144291, DOI: 10.1038/s41537-025-00622-0.

  Peer-Reviewed Original Research

  Altmetric

  Concepts

• Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

  Wigman J, Ching A, Chung Y, Eichi H, Lane E, Langholm C, Vaidyam A, Byun A, Haidar A, Hartmann J, Nunez A, Dwyer D, Nasarudin A, Borders O, Scott I, Tamayo Z, Matneja P, Cho K, Addington J, Alameda L, Arango C, Breitborde N, Broome M, Cadenhead K, Calkins M, Chen E, Choi J, Conus P, Corcoran C, Cornblatt B, Diaz-Caneja C, Ellman L, Fusar-Poli P, Gaspar P, Gerber C, Glenthøj L, Horton L, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim S, Koutsouleris N, Langbein K, Mamah D, Mathalon D, Mittal V, Nordentoft M, Pearlson G, Perez J, Perkins D, Powers A, Rogers J, Sabb F, Schiffman J, Shah J, Silverstein S, Smesny S, Yassin W, Stone W, Strauss G, Thompson J, Upthegrove R, Verma S, Wang J, Wolf D, Wolff P, Rowland L, D’Alfonso S, Pasternak O, Bouix S, McGorry P, Kahn R, Kane J, Bearden C, Woods S, Shenton M, Nelson B, Baker J, Torous J. Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program. Schizophrenia 2025, 11: 83. PMID: 40461469, PMCID: PMC12134270, DOI: 10.1038/s41537-025-00599-w.

  Peer-Reviewed Original Research

  Altmetric

  Concepts

• Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations

  Perkins D, Jeffries C, Clark S, Upthegrove R, Wannan C, Wray N, Li Q, Do K, Walker E, Paul Amminger G, Anticevic A, Cotter D, Ellman L, Mongan D, Phassouliotis C, Barbee J, Roth S, Billah T, Corcoran C, Calkins M, Cerrato F, Khadimallah I, Klauser P, Winter-van Rossum I, Nunez A, Bleggi R, Martin A, Bouix S, Pasternak O, Shah J, Toben C, Wolf D, Kahn R, Kane J, McGorry P, Bearden C, Nelson B, Shenton M, Woods S. Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations. Schizophrenia 2025, 11: 78. PMID: 40399418, PMCID: PMC12095529, DOI: 10.1038/s41537-025-00610-4.

  Peer-Reviewed Original Research

  Altmetric

  Concepts

• Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates

  Tran T, Keane B, Thompson J, Robinson B, Kenney J, Williams T, Waltz J, Levin J, Kafadar E, Gold J, Schiffman J, Ellman L, Walker E, Strauss G, Mittal V, Zinbarg R, Corlett P, Powers A, Woods S, Silverstein S. Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates. Schizophrenia 2025, 11: 74. PMID: 40355455, PMCID: PMC12069608, DOI: 10.1038/s41537-025-00624-y.

  Peer-Reviewed Original Research

  Altmetric

  Concepts

• Altered brain activation during memory retrieval mediates the relationship between developmental trauma and psychotic symptom severity

  Mason A, Palmer W, Cao H, Addington J, Bearden C, Cadenhead K, Cornblatt B, Perkins D, Mathalon D, Walker E, Woods S, Cannon T. Altered brain activation during memory retrieval mediates the relationship between developmental trauma and psychotic symptom severity. Schizophrenia Research 2025, 281: 115-121. PMID: 40328092, DOI: 10.1016/j.schres.2025.04.034.

  Peer-Reviewed Original Research

  MeSH Keywords and Concepts

• Trajectories of positive symptoms and suicidality in individuals at clinical high risk for psychosis

  Deng W, MacNutt C, Addington J, Bearden C, Cadenhead K, Carrión R, Keshavan M, Mathalon D, Perkins D, Stone W, Walker E, Woods S, Cannon T. Trajectories of positive symptoms and suicidality in individuals at clinical high risk for psychosis. Journal Of Affective Disorders 2025, 384: 208-213. PMID: 40334865, DOI: 10.1016/j.jad.2025.05.023.

  Peer-Reviewed Original Research

  Altmetric

  MeSH Keywords and Concepts

• Mismatch Negativity as a Predictor of Future Outcomes Among Individuals at Clinical High-Risk for Psychosis: Parsing Components of Auditory Predictive Coding in the North American Psychosis-Risk Longitudinal Study (NAPLS3) Sample

  Hamilton H, Nicholas S, Hua J, Roach B, Belger A, Carrion R, Duncan E, Johannesen J, Keshavan M, Loo S, Niznikiewicz M, Light G, Billah T, Lavoie S, Whitford T, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Perkins D, Stone W, Tsuang M, Walker E, Woods S, Mathalon D, Schizophrenia A. Mismatch Negativity as a Predictor of Future Outcomes Among Individuals at Clinical High-Risk for Psychosis: Parsing Components of Auditory Predictive Coding in the North American Psychosis-Risk Longitudinal Study (NAPLS3) Sample. Biological Psychiatry 2025, 97: s69. DOI: 10.1016/j.biopsych.2025.02.180.

  Peer-Reviewed Original Research

  Concepts

• Cognitive Assessment in the AMP SCZ Initiative: Harmonization Priorities and Strategies in a Diverse International Sample

  Yassin W, Allott K, Bearden C, Lewandowski K, Matneja P, Zoupou E, Ruparel K, Parsa S, Ray S, Santorelli G, Wannan C, Keshavan M, Wood S, Kane J, Shenton M, Nelson B, Woods S, Gur R, Stone W, Schizophrenia A. Cognitive Assessment in the AMP SCZ Initiative: Harmonization Priorities and Strategies in a Diverse International Sample. Biological Psychiatry 2025, 97: s69-s70. DOI: 10.1016/j.biopsych.2025.02.181.

  Peer-Reviewed Original Research

  Concepts

• 571. Preliminary Findings on the Association Between Psychotropic Medication and Symptom Profile Changes in Youth at Clinical High Risk for Psychosis

  Zhou Q, Ananth A, Yuan E, Ku B, Goldsmith D, Addington J, Bearden C, Cadenhead K, Mukhtar H, Cannon T, Cornblatt B, Keshavan M, Mathalon D, Perkins D, Stone W, Woods S, Walker E. 571. Preliminary Findings on the Association Between Psychotropic Medication and Symptom Profile Changes in Youth at Clinical High Risk for Psychosis. Biological Psychiatry 2025, 97: s333-s334. DOI: 10.1016/j.biopsych.2025.02.810.

  Peer-Reviewed Original Research

  Concepts